Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Sep 06, 2014 10:58am
145 Views
Post# 22912460

RE:RE:RE:RE:RE:Zenith & RVX status

RE:RE:RE:RE:RE:Zenith & RVX statusHi SanFran and thanks as always for your deep digging to get information.

"It's all a mystery really" exactly underscores the issue with both Zenith and RVX. It's a pathetic situation.

Sure makes me wonder why they are so secretative. These things should be clear and communicated but they don't care because they are all well compensated.

It does seem to me that Zenith may need to source funds for research and this raises some questions. If they do an IPO then I would think that there will be dilution of our share value offset by positive demand of the market (which would be wonderful). I wonder what Eastern and NGN's position would be on this. An effective epi-genetic factory on any of the platforms including various cancers could be worth billions.

GLTA
toinv
Bullboard Posts